Invest BW
VC Fund
Invest BW is a funding program.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Invest BW invests in
Stages Invest BW invests in
Countries Invest BW invests in
Round sizes
Round size
- Grant
- $215k–$2.4M
- Series A
- $1.1M–$18M
Investment Focus
Industry
- Health Care 2 (29%)
- Biotechnology 2 (29%)
- Medical Device 2 (29%)
- AgTech 1 (14%)
- Medical 1 (14%)
Stage
- Grant 2 (29%)
- Series A 2 (29%)
- Seed 1 (14%)
- Series B 1 (14%)
- Venture - Series Unknown 1 (14%)
Country
- Belgium 4 (57%)
- Germany 2 (29%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
IONNYK
|
IONNYK is the first art photography platform that elevates the art experience while allowing for imagination and originality. | $1.6M / Venture - Series Unknown / Jun 13, 2023 | |
VCG.AI
|
The Intelligence Behind Global Circularity VCG.AI transforms industrial by-products and waste into valuable resources.AI-powered development of circular economy business models with the latest technology, material, market, and regulatory insights.Their proprietary AI solution, the Value Chain Generator®, helps companies, cities, and regionsaccelerate the transition to a circular economy, throughValorisation of By-products and Waste, Circular Product Development, Regional Circular Opportunities Assessment. When organisations want to better valorise by-products and waste, develop or source circular materials, or enhance circularity in their value chains, VCG.AI analyses thousands of data points to deliver the optimal solution tailored to their specific needs and locations. What once took months or years can now be achieved in just weeks—without the need to hire additional technology or bioeconomy experts. VCG.AI’s ever-expanding system includes: - 650+ validated circular solutions - 150+ different proven valorisation technologies - 3.5 M companies - 4M tons of project-ready organic residuals across EuropeVCG.AI is on a mission to accelerate the transition to a circular economy by unlocking circular opportunities for businesses worldwide. Learn more about them at www.vcg.ai. | $214.6K / Grant / May 26, 2023 | |
Minagro
|
Minagro develops high-quality green products for crop care. Minagro conducts research activities in confirmed proprietary technologies from green and specialty chemistries. | $1.3M / Seed / Apr 18, 2023 | |
Sunrise
|
Sunrise aims to bring simple answers to millions of people suffering from sleep disorders.We have developed a 3-gram sensor to diagnose sleep with gold standard quality. The technology offers a revolutionary new way to measure brain commands at night, with published clinical results never seen before. Studies demonstrate Sunrise is as accurate asin-lab sleep studies, at a fraction of the cost.Affecting one in three people, sleep disorders are extremely common. Sleep apnea is the most prevalent disease with almost 1 billion persons concerned. This condition leads to great body damage over time and yet remains undiagnosed in 80% of the cases.Patients, caregiver and insurers stand to benefit greatly from a solution to current highly cumbersome, expensive and time-consuming diagnostics systems. | $18M / Series A / Mar 09, 2023 | |
|
IONNYK
|
IONNYK is the first art photography platform that elevates the art experience while allowing for imagination and originality. | $1.1M / Series A / Jan 27, 2022 | |
Novadip Biosciences
|
Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction. | $22.2M / Series B / Oct 28, 2021 | |
NVision Quantum Technologies
|
NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware intoscalable products.Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact. | $2.4M / Grant / Aug 01, 2021 |
Co-Investors
Vives Louvain Technology Fund
2 deals together
WING by Digital Wallonia
2 deals together
Amazon Alexa Fund
1 deal together
Beangels
1 deal together
European Innovation Council
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Invest BW invest in?
Invest BW invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Grant and Series A stage. Most of the 7 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Invest BW's check size?
Invest BW typically joins rounds of $215k–$2.4M at Grant and $1.1M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Invest BW participates in.
When did Invest BW last invest?
The most recent investment recorded for Invest BW closed in Jun 2023. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
